University of Arizona

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Arizona sits in the top decile of US sponsors by registered trial count (#101 of 15,742 sponsors by registered trial count).

349 total trials 56 currently recruiting 213 completed early-phase tilt top decile by trial count

University of Arizona: 349 sponsored US clinical trials, 56 recruiting.

University of Arizona sponsors 349 registered US clinical trials on ClinicalTrials.gov, 56 of them currently recruiting, and 213 completed. 21 of these trials are in Phase 3-4 (later-stage) and 100 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 6 trials.

Top-decile sponsor footprint

University of Arizona ranks in the top decile of sponsors by registered trial count (#101 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 44/100

213 of 260 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

349 total, page 5 of 7

TERMINATED Phase 2

Evaluation of the Safety and Efficacy of Ang-(1-7) to Enhance Cognitive Function in Participants Undergoing CABG

NCT03252093

COMPLETED NA

Quantifying the Efficacy and Role of Service Dogs for Military Veterans With PTSD

NCT03245814

COMPLETED Phase 4

Oxytocin Dosage to Decrease Induction Duration

NCT03140488

COMPLETED NA

Animated Video Consultation for Reducing Pre-Operative Anxiety in Outpatient Dermatologic Surgery

NCT03344497

TERMINATED NA

Evaluating the Effects of Cleansers on the Skin

NCT03188653

COMPLETED Early Phase 1

Broccoli Sprout Extract in Preventing Recurrence in Patients With Tobacco-Related Head and Neck Squamous Cell Cancer

NCT03182959

COMPLETED NA

Skin Barrier Biophysical Properties and Clinical Appearance After Moisturizer in Dry Skin

NCT03093597

COMPLETED

Risk Factors for Thrombosis in Children With Central Venous Lines

NCT04117217

COMPLETED Phase 2

Oral Bacterial Extract for the Prevention of Wheezing Lower Respiratory Tract Illness

NCT02148796

COMPLETED NA

The Effects of Dexamethasone on the Time to Pain Resolution in Dental Periapical Abscess

NCT03005522

COMPLETED Phase 1

Haploidentical BMT With Post-Transplant Cyclophosphamide and Bendamustine

NCT02996773

COMPLETED

Epigenetics of Muscle Insulin Resistance

NCT03259984

COMPLETED NA

Quadrivas Therapy® to Reduce Lipedema Subcutaneous Adipose Tissue (QUADRIVAS)

NCT02907411

COMPLETED NA

Preventing Avoidable Admissions Among Assisted Living Elders

NCT02879396

COMPLETED NA

Feasibility and Acceptability of a Beverage Intervention for Hispanic Adults

NCT02911753

COMPLETED NA

Gender- and Culturally-Sensitive Weight Loss Intervention for Hispanic Males

NCT02783521

COMPLETED

Kids Intestinal Dysfunction in Congenital Heart Disease: the Kind Heart Study

NCT02824705

COMPLETED NA

Promoting Adherence to Treatment for Latent TB Infection Through Text Messaging

NCT02690818

COMPLETED NA

Inspiratory Muscle Strength Training for Sleep-related Breathing Disorders

NCT02709941

TERMINATED NA

Early Coronary Angiography Versus Delayed Coronary Angiography

NCT02387398

COMPLETED Phase 1

Photodynamic Therapy and Vismodegib for Multiple Basal Cell Carcinomas

NCT02639117

COMPLETED NA

Pan-Asia United States PrEvention of Sudden Cardiac Death Catheter Ablation Trial

NCT02848781

TERMINATED Phase 1

Curcuma Longa L in Rheumatoid Arthritis

NCT02543931

TERMINATED NA

Metabolomic Analysis of the Impacts of Hydration Status on Exercise Performance

NCT02486224

COMPLETED NA

Exercise and Asthma in Obese Adults

NCT03145883

COMPLETED NA

Negative Pressure Wound Therapy to Prevent Wound Complications Following Cesarean Section in High Risk Patients

NCT03082664

COMPLETED NA

Connecting Healthy Women: Examining the Effect of an Intervention From the Effect of Being Reachable

NCT02157168

COMPLETED NA

Oxytocin and Approach-avoid in Grief

NCT04505904

COMPLETED Phase 2

Dogs as Probiotics

NCT02343731

TERMINATED

Pill Study Hyperthermia Device (Heckel HT 3000): Monitoring Core Body Temperature Using Wireless Technology

NCT02340377

COMPLETED NA

Bright Light Therapy for Treatment of Sleep Problems Following Mild Traumatic Brain Injury

NCT02374918

COMPLETED NA

Prone Breath Hold Technique to Decrease Cardiac and Pulmonary Doses in Women Receiving Left Breast Radiotherapy

NCT02379988

COMPLETED NA

Evaluation of Pathway Modulation by Raf, MEK, & Kinase Inhibitors

NCT03176485

COMPLETED NA

Intense Physiotherapies to Improve Function in Young Children With Cerebral Palsy

NCT02167022

COMPLETED NA

A Non-Pharmacological Method for Enhancing Sleep in PTSD

NCT02370173

TERMINATED Phase 2

Dexamethasone for Treatment of Radiation-related Fatigue in Patients Receiving RT for Head-neck and Lung Cancer

NCT02410382

COMPLETED Phase 4

Supervised Asthma Medication in Schools (SAMS)

NCT01997463

TERMINATED Early Phase 1

An Early Phase Clinical Trial to Evaluate the Feasibility of CEST MRI in Patients With Early Stage Breast Cancer

NCT02380209

COMPLETED NA

Virtual Reality Based Balance Training in People With Mild Cognitive Impairment

NCT02214342

TERMINATED

Whole Body Hyperthermia Registry Study

NCT02174003

COMPLETED NA

Vacuum Assisted Therapy in Emergent Contaminated Abdominal Surgeries

NCT02127164

COMPLETED Phase 2

Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer Risk

NCT02028221

TERMINATED NA

Whole Body Hyperthermia & Combat-Related Posttraumatic Stress Disorder (PTSD)

NCT02077972

TERMINATED Phase 2

Vismodegib in Basal Cell Carcinomas (BCC) Chemoprevention

NCT02067104

COMPLETED NA

The Brain on Whole Body Hyperthermia: A Neuroimaging Study

NCT02062840

COMPLETED NA

Johrei Therapy and CBT-I in Facilitating Sleep in ICU Survivors

NCT02059421

TERMINATED Phase 2

A Phase II Study of Vemurafenib Combined With Acitretin in Patients With Advanced Melanoma

NCT02050321

TERMINATED Phase 2

Correlate BRCA1 Protein Expression With Response to DNA Damaging Chemotherapy

NCT01990352

COMPLETED NA

Virtual Reality-based Exercise in Older Adults

NCT02043834

COMPLETED NA

Virtual Reality-Based Exercise in Cancer Patients

NCT02165163

← Previous Page 5 of 7 Next →

Phase Distribution

PhaseTrial count
Phase 1 43
Phase 2 57
Phase 3 8
Phase 4 13

What is open in the University of Arizona pipeline

56 recruiting of 349 indexed (16% open); 213 completed (61%).

Phase mix: 21 late (III/IV) vs 100 early (I/II) (early-phase heavy).

Top condition: Breast Cancer (6 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Arizona: open-pipeline peers nationwide

Peers matched on 349 registered trials and 16% open enrollment, not the therapeutic-area sidebar.

University of Arizona sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,5002,000 5%10%15%20%25% Total trials Recruiting share University of ArizonaMontefiore Medical CenterNational Institute of Mental Health (NIMH)Children's Oncology GroupOhio State University Comprehensive Cancer CenterECOG-ACRIN Cancer Research GroupGeorge Mason UniversityUniversity of California, San FranciscoNational Human Genome Research Institute (NHGRI)
University of Arizona sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Arizona sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 349 trials (± recruiting share)

Sponsors near 16% open enrollment (± trial volume)

What to do with this University of Arizona page

349 registered trials is a research-attention snapshot, not an endorsement of University of Arizona or any single study.

  • 56 of University of Arizona's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Breast Cancer is the condition University of Arizona studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of Arizona pipeline card: 349 registered trials from official public datasets.Report a data error.